Agilent Technologies, Inc. $A Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its position in Agilent Technologies, Inc. (NYSE:A) by 3.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,544,780 shares of the medical research company’s stock after selling 101,678 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Agilent Technologies were worth $338,023,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after acquiring an additional 24,687 shares during the period. Bank of Nova Scotia acquired a new position in Agilent Technologies during the second quarter valued at $58,539,000. Dudley & Shanley Inc. boosted its holdings in Agilent Technologies by 25.9% in the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after purchasing an additional 14,300 shares during the last quarter. BIP Wealth LLC purchased a new stake in Agilent Technologies in the second quarter valued at $834,000. Finally, Crossmark Global Holdings Inc. grew its position in Agilent Technologies by 39.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after purchasing an additional 9,615 shares during the period.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, August 2nd. HSBC reduced their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Stifel Nicolaus boosted their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Bank of America upped their price objective on Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a research note on Thursday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $170.33.

Agilent Technologies Stock Performance

NYSE A opened at $153.79 on Tuesday. The stock has a market capitalization of $43.43 billion, a price-to-earnings ratio of 30.27, a PEG ratio of 2.34 and a beta of 1.25. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $163.75. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50. The stock has a 50-day moving average of $140.85 and a 200 day moving average of $127.21.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.Agilent Technologies’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same period last year, the company earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.